IN VIVO ANTIOXIDANT AND HEPATOPROTECTIVE EFFECTS OF HUGONIA MYSTAX IN PARACETAMOL INDUCED HEPATOTOXICITY IN RATS.

  • Devendra Shriram Shirode Savitribai phule pune university, pune
  • Brijendra B Jain
  • Mahendra Kumar C B

Abstract

Objectives: The objective of the present work is to study the in vivo anti-oxidant and hepatoprotective effects of Hugonia mystax in paracetamol (PCM)
induced hepatotoxicity in rats.
Methods: The in vivo anti-oxidant activity of 70% ethanol extract of leaves of H. mystax (HMEE) was assessed by determining the tissue glutathione
and lipid peroxidation (LPO) levels. HMEE 200 and 400 mg/kg p.o. doses and silymarin p.o.100 mg/kg were administered to the PCM challenged
rats. The effect of HMEE and silymarin on physical (liver weight and liver volume) and biochemical parameters (serum enzymes [serum glutamic
oxaloacetic transaminase (SGOT) and serum glutamate-pyruvate transaminase (SGPT)], alkaline phosphate [ALP], and bilirubin) were measured.
Furthermore, histopathological changes in the liver were studied.
Results: The HMEE showed in the vivo anti-oxidant activity. Pre-treatment with HMEE for 7 days significantly reduced the elevated biochemical
parameters (SGOT, SGPT, ALP, and bilirubin levels). The hepatic damage in animal pretreated with HMEE was minimal with distinct preservation of
structures and architectural frame of the hepatic cells.
Conclusion: These findings demonstrate the protective nature of HMEE against PCM
Keywords: Hugonia mystax, Hepatoprotective, In vivo anti-oxidant, Paracetamol.

Author Biography

Devendra Shriram Shirode, Savitribai phule pune university, pune
Pharmacology and Asst. Prof.

References

1. Jafri MA, Jalis Subhani M, Javed K, Singh S. Hepatoprotective activity
of leaves of Cassia occidentalis against paracetamol and ethyl alcohol
intoxication in rats. J Ethnopharmacol 1999;66(3):355-61.
2. Kritikar KR, Basu BD. Indian Medicinal Pants. Dehradun: Bishen
Singh Mahendra Pal Singh; 1999. p. 412-3.
3. Vaidyaratnum PS. Indian Medicinal Plants. Arya Vaidyasala, Kottakkal:
Orient Longman; 1995. p. 183-4.
4. Nadkarni AK. Indian Materia Medica. Mumbai: Bombay Popular
Prakashan; 2002. p. 655-6.
5. Vimalavady A, Kadavul K, Tangavelou AC. Phytochemical screening
and antimicrobial activity on the fruits of Hugonia mystax L.
(Lineaceae). IJPSR 2012;3(4):1178-83.
6. Vimalavady A, Kadavul K, Tangavelou AC. Phytochemistry and
antimicrobial activity of Hugonia mystax L. (Lineaceae). Int J Pharm
Pharm Sci 2012;4(1): 381-4.
7. Vimalavady A, Kadavul K. Phytochemical screening and antimicrobial
activity on the leaves of Hugonia mystax Linn. (Lineaceae). Indian I
Nat Prod Resour 2012;3(2): 161-5.
8. Rajeswari G, Murugan M, Mohan VR. Anti-inflammatory activity of
leaf and bark of Hugonia mystax L. (Lineaceae). J Horm Res Pharm
2013;2(2):80-3.
248
Asian J Pharm Clin Res, Vol 8, Issue 5, 2015, 246-249
Shirode et al.
9. Anandkumar S, Karmegram N. In vitro cytotoxic evaluation of Hugonia
mystax Linn leaf and stem bark extracts. Int J Bot 2011;7(4):300-4.
10. Mohankumar M, Lalitha V. In vitro anthelmintic activity of Hugonia
mystax leaves Linn in Indian adult earthworm. J Pharm Phytochem
2015;3(5):19-21.
11. Tiwari KA. Imbalance in antioxidant defence and human disease. Curr
Sci 2001;81:1179-86.
12. Veeraraghavan P. Expert consultant, CPCSEA, OECD Guideline
No. 420; Oct, 2000.
13. Chattopadhyay RR. Possible mechanism of hepatoprotective activity of
Azadirachta indica leaf extract: Part II. J Ethnopharmacol 2003;89(23):217-9.
14. Bradley DW, Maynard JE, Emery G, Webster H. Transaminase
activities in serum of long-term hemodialysis patients. Clin Chem
1972;18(11):1442.
15. Rej R, Fasce CF Jr, Vanderlinde RE. Increased aspartate
aminotransferase activity of serum after in vitro supplementation with
pyridoxal phosphate. Clin Chem 1973;19(1):92-8.
16. McComb RB, Bowers GN Jr. Study of optimum buffer conditions for
measuring alkaline phosphatase activity in human serum. Clin Chem
1972;18(2):97-104.
17. Pearlman FC, Lee RT. Detection and measurement of total bilirubin
in serum, with use of surfactants as solubilizing agents. Clin Chem
1974;20:447-53.
18. Aykaç G, Uysal M, Yalçin AS, Koçak-Toker N, Sivas A, Oz H.
The effect of chronic ethanol ingestion on hepatic lipid peroxide,
glutathione, glutathione peroxidase and glutathione transferase in rats.
Toxicology 1985;36(1):71-6.
19. John BA, Steven AD. Microsomal Lipid Peroxidation. London: Moury
Kleiman Co.; 1978. p. 302.
20. Janbaz KH, Saeed SA, Gilani AH. Protective effect of rutin on
paracetamol- and CCl4-induced hepatotoxicity in rodents. Fitoterapia
2002;73(7-8):557-63.
21. Wells FE. Tests in liver and biliary tract disease. In: Gowenlock HA
editor. Varley’s Practical Clinical. Florida: CRC Press; 1988.
22. Zimmerman HJ, Seef LB. Enzymes in hepatic disease. In:
Goodly EI, editor. Diagnostic Enzymology. Philadelphia: Lea and
Febiger; 1970.
23. Drotman RB, Lawhorn GT. Serum enzymes as indicators of chemically
induced liver damage. Drug Chem Toxicol 1978;1(2):163-71.
24. Rao RR. Mechanism of drug induced hepatotoxicity. Indian J Pharm
1973;5:313-8.
Statistics
112 Views | 279 Downloads
How to Cite
Shirode, D. S., B. B. Jain, and M. K. C B. “IN VIVO ANTIOXIDANT AND HEPATOPROTECTIVE EFFECTS OF HUGONIA MYSTAX IN PARACETAMOL INDUCED HEPATOTOXICITY IN RATS.”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 8, no. 5, Sept. 2015, pp. 291-4, https://innovareacademics.in/journals/index.php/ajpcr/article/view/7489.
Section
Original Article(s)